- Aripiprazole tablets are now available as a generic for the treatment of schizophrenia in adults.
- Actavis has launched Sastravi (levodopa/carbidopa/entacapone) for the treatment of Parkinson's disease and end-of-dose motor fluctuations not stabilised with levodopa/dopa decarboxylase inhibitor.
- Sanofi has discontinued Piportil Depot (pipotiazine palmitate) owing to a global shortage of the active ingredient. Supplies of the injection are expected to be exhausted by the end of March 2015.
- Novartis has announced the discontinuation of Tegretol Chewtabs (carbamazepine). Selection of an alternative medication should be a clinical decision based on the individual patient's history.
- The antiemetic domperidone (Motilium) will now be available only as a POM.
- Scopoderm (hyoscine hydrobromide) patches can now be bought without a prescription from pharmacies for the treatment of travel sickness. Each 1.5mg patch can be used for up to 72 hours.
- The NMDA antagonist memantine is now available as a generic tablet for the treatment of moderate to severe Alzheimer's dementia.
Register or Subscribe to MIMSGPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.
MIMS bulletinsNews and updates straight to your inbox.
Prescribing Update: Fortnightly news bulletin
Alert: Urgent prescribing updates
Spotlight: Disease-themed monthly round-up
Read the latest issue online exclusively on MIMS Learning.
Especially created for prescribing influencers.